Related Experiment Video
Updated: May 29, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
Published on: June 30, 2023
Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death
Pradeep K Kamat1, Santoshkumar Tota, Rakesh Shukla
1Division of Pharmacology, Central Drug Research Institute, P.O. Box 173, Lucknow (U.P.) 226001, India.
Abstract:
Mitochondrial abnormalities have been identified in a large proportion of neurodegenerative diseases. Recently we have reported that intracerebroventricular (ICV) administration of okadaic acid (OKA) causes memory impairment in rat. However involvement of mitochondrial function in OKA induced memory impairment and neuronal damage has not been determined. OKA (200 ng) was administered by ICV route. After 13th day of OKA administration memory function was evaluated by Morris Water Maze test. Following completion of behavioral studies on 16th day, mitochondrial membrane potential, Ca(2+) and reactive oxygen species were evaluated in mitochondrial preparation of cortex, hippocampus, striatum and cerebellum of rat brain. While ATP, mitochondrial activity, lipid peroxidation and nitrite were investigated in synaptosomal preparation of rat brain areas. The activities and mRNA expression of apoptotic factors, caspase-3 and caspase-9, were studied in rat brain regions. The neuronal damage was also confirmed by histopathological study. OKA treated rats showed memory impairment including increased Ca(2+) and reactive oxygen species and decreased mitochondrial membrane potential, ATP and mitochondrial activity in mitochondrial preparation. There was a significant increase in lipid peroxidation and nitrite in synaptosomal preparations. Preventive treatment daily for 13 days with antidementic drugs, donepezil (5 mg/kg, p.o) and memantine (10 mg/kg, p.o), significantly attenuated OKA induced mitochondrial dysfunction, apoptotic cell death, memory impairment and histological changes. Mitochondrial dysfunction appeared as a key factor in OKA induced memory impairment and apoptotic cell death. This study indicates that clinically used antidementic drugs are effective against OKA induced adverse changes at behavioral, cellular, and histological levels and mitochondrial dysfunction.
Insights
Okadaic acid (OKA) induces memory loss and neuronal damage by disrupting mitochondrial function. Clinically used drugs like donepezil and memantine effectively prevent these adverse effects, highlighting mitochondria
Area of Science:
- Neuroscience
- Mitochondrial Biology
- Pharmacology
Background:
- Mitochondrial dysfunction is implicated in neurodegenerative diseases.
- Okadaic acid (OKA) administration causes memory impairment in rats.
- The role of mitochondrial function in OKA-induced neurodegeneration is unclear.
Purpose of the Study:
- To investigate the involvement of mitochondrial dysfunction in OKA-induced memory impairment and neuronal damage.
- To evaluate the therapeutic potential of donepezil and memantine in mitigating these effects.
Main Methods:
- Intracerebroventricular (ICV) administration of OKA in rats.
- Behavioral testing (Morris Water Maze) to assess memory function.
- Biochemical assays for mitochondrial membrane potential, ATP, reactive oxygen species, lipid peroxidation, and nitrite.
- Analysis of apoptotic factors (caspase-3, caspase-9) and histopathological examination.
- Assessment of preventive treatment with donepezil and memantine.
Main Results:
- OKA treatment led to memory impairment, decreased mitochondrial membrane potential, ATP levels, and mitochondrial activity.
- Increased Ca(2+), reactive oxygen species, lipid peroxidation, and nitrite were observed in OKA-treated rats.
- OKA induced apoptotic cell death and histological neuronal damage.
- Donepezil and memantine significantly attenuated OKA-induced memory deficits, mitochondrial dysfunction, apoptosis, and histological changes.
Conclusions:
- Mitochondrial dysfunction is a key factor in OKA-induced memory impairment and neuronal damage.
- Clinically used antidementic drugs demonstrate efficacy in preventing OKA-induced adverse effects at behavioral, cellular, and histological levels.
- Targeting mitochondrial dysfunction offers a potential therapeutic strategy for neurodegenerative conditions.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cellular Injury IV: Necrosis
Mitochondrial Membranes

